• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不耐受家庭肠内营养患者转为基于肽的饮食后,医疗保健利用率降低。

Reduction in Healthcare Utilization With Transition to Peptide-Based Diets in Intolerant Home Enteral Nutrition Patients.

机构信息

Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota, USA.

Division of General Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.

出版信息

Nutr Clin Pract. 2020 Jun;35(3):487-494. doi: 10.1002/ncp.10477. Epub 2020 Mar 9.

DOI:10.1002/ncp.10477
PMID:32149433
Abstract

BACKGROUND

Since the introduction of percutaneous endoscopic gastrostomy in the 1980s, the prevalence of home enteral nutrition (HEN) support has increased significantly. Despite these increases, many patients are unable to tolerate standard polymeric formulas (SPFs), resulting in significant healthcare resource utilization. Peptide-based diets (PBDs) have emerged as a viable option in SPF-intolerant patients; however, data in the HEN population are lacking.

METHODS

Retrospective review of our prospectively maintained HEN database was conducted to assess tolerance, efficacy, and impact on healthcare utilization in patients on PBDs.

RESULTS

From January 1, 2016, to May 1, 2018, 95 patients were placed on PBDs, with 53 patients being started directly and 42 patients being transitioned from SPFs. In patients transitioned to PBDs, symptoms of nausea and vomiting, diarrhea, abdominal pain, and distention improved significantly. Healthcare utilization also declined significantly, including mean number of phone calls (1.8 ± 1.6 to 1.1 ± 0.9, P = 0.006), mean number of emergency room visits (0.3 ± 0.6 to 0.09 ± 0.3, P = 0.015), and mean number of provider visits (1.3 ± 1.3 to 0.3 ± 0.5, P < 0.0001).

CONCLUSIONS

Overall, PBDs were well tolerated and resulted in significant improvements in symptoms of gastrointestinal distress and healthcare utilization in patients intolerant to SPFs.

摘要

背景

自 20 世纪 80 年代引入经皮内镜胃造口术以来,家庭肠内营养(HEN)支持的患病率显著增加。尽管有所增加,但许多患者无法耐受标准聚合物配方(SPF),导致大量医疗资源被利用。基于肽的饮食(PBD)在 SPF 不耐受患者中已成为一种可行的选择;然而,在 HEN 人群中缺乏相关数据。

方法

对我们前瞻性维护的 HEN 数据库进行回顾性审查,以评估 PBD 不耐受患者的耐受性、疗效以及对医疗保健利用的影响。

结果

从 2016 年 1 月 1 日至 2018 年 5 月 1 日,95 名患者开始使用 PBD,其中 53 名患者直接开始使用,42 名患者从 SPF 转换而来。在转为 PBD 的患者中,恶心和呕吐、腹泻、腹痛和腹胀等症状明显改善。医疗保健利用也显著下降,包括平均电话次数(1.8±1.6 次至 1.1±0.9 次,P=0.006)、平均急诊就诊次数(0.3±0.6 次至 0.09±0.3 次,P=0.015)和平均就诊次数(1.3±1.3 次至 0.3±0.5 次,P<0.0001)。

结论

总体而言,PBD 耐受性良好,可显著改善 SPF 不耐受患者的胃肠道不适症状和医疗保健利用。

相似文献

1
Reduction in Healthcare Utilization With Transition to Peptide-Based Diets in Intolerant Home Enteral Nutrition Patients.不耐受家庭肠内营养患者转为基于肽的饮食后,医疗保健利用率降低。
Nutr Clin Pract. 2020 Jun;35(3):487-494. doi: 10.1002/ncp.10477. Epub 2020 Mar 9.
2
Transition to peptide-based diet improved enteral nutrition tolerance and decreased healthcare utilization in pediatric home enteral nutrition.肽基饮食过渡可改善儿科家庭肠内营养的耐受性并降低医疗保健利用率。
JPEN J Parenter Enteral Nutr. 2022 Mar;46(3):626-634. doi: 10.1002/jpen.2202. Epub 2021 Jul 19.
3
Complications Associated with Enteral Nutrition: CAFANE Study.肠内营养相关并发症:CAFANE 研究。
Nutrients. 2019 Sep 1;11(9):2041. doi: 10.3390/nu11092041.
4
Cross-sectional Evaluation of Home Enteral Nutrition Practice in the United States in the Context of the New Enteral Connectors.美国新型肠内营养连接器背景下的家庭肠内营养实践的横断面评估。
JPEN J Parenter Enteral Nutr. 2019 Nov;43(8):1020-1027. doi: 10.1002/jpen.1510. Epub 2019 Feb 7.
5
Home enteral nutrition in children: an 11-year experience with 416 patients.儿童家庭肠内营养:416例患者的11年经验
Clin Nutr. 2005 Feb;24(1):48-54. doi: 10.1016/j.clnu.2004.07.004.
6
Home Enteral Nutrition in Adults-Nationwide Multicenter Survey.成人家庭肠内营养-全国多中心调查。
Nutrients. 2020 Jul 14;12(7):2087. doi: 10.3390/nu12072087.
7
Experience over 12 years with home enteral nutrition in a healthcare area of Spain.在西班牙的一个医疗保健领域拥有超过 12 年的家庭肠内营养经验。
J Hum Nutr Diet. 2013 Jul;26 Suppl 1:39-44. doi: 10.1111/jhn.12081. Epub 2013 May 7.
8
Home enteral nutrition in adults: a European multicentre survey.成人家庭肠内营养:一项欧洲多中心调查。
Clin Nutr. 2003 Jun;22(3):261-6. doi: 10.1016/s0261-5614(03)00005-0.
9
Dramatic changes in home-based enteral nutrition practices in children during an 11-year period.11年间儿童家庭肠内营养实践的显著变化。
J Pediatr Gastroenterol Nutr. 2006 Aug;43(2):240-4. doi: 10.1097/01.mpg.0000228095.81831.79.
10
THE EVOLUTION OF HOME ENTERAL NUTRITION (HEN) IN POLAND DURING FIVE YEARS AFTER IMPLEMENTATION: A MULTICENTRE STUDY.波兰实施家庭肠内营养(HEN)五年后的发展:一项多中心研究。
Nutr Hosp. 2015 Jul 1;32(1):196-201. doi: 10.3305/nh.2015.32.1.8819.

引用本文的文献

1
Protective nutrition strategy in the acute phase of critical illness: why, what and how to protect.危重症急性期的保护性营养策略:为何要保护、保护什么以及如何进行保护。
Front Nutr. 2025 May 9;12:1555311. doi: 10.3389/fnut.2025.1555311. eCollection 2025.
2
Gastrointestinal changes in paediatric malnutrition that may impact on nutrition choice.可能影响营养选择的小儿营养不良中的胃肠道变化。
Front Pediatr. 2025 Mar 10;13:1523613. doi: 10.3389/fped.2025.1523613. eCollection 2025.
3
The Application and Mechanism Analysis of Enteral Nutrition in Clinical Management of Chronic Diseases.
肠内营养在慢性病临床管理中的应用及机制分析
Nutrients. 2025 Jan 26;17(3):450. doi: 10.3390/nu17030450.
4
Enteral Nutrition Therapy: Historical Perspective, Utilization, and Complications.肠内营养治疗:历史视角、应用及并发症。
Curr Gastroenterol Rep. 2024 Aug;26(8):200-210. doi: 10.1007/s11894-024-00934-8. Epub 2024 May 24.
5
Discharged on Enteral Nutrition: What Now? The Poor State of Outpatient Support for Patients on Enteral Nutrition Support.经肠内营养出院:现在该怎么办?肠内营养支持患者门诊支持的糟糕状况。
Curr Gastroenterol Rep. 2023 Mar;25(3):61-68. doi: 10.1007/s11894-023-00864-x. Epub 2023 Feb 3.
6
Foods for Special Medical Purposes in Home Enteral Nutrition-Clinical Practice Experience. Multicenter Study.家庭肠内营养中特殊医学用途食品——临床实践经验。多中心研究。
Front Nutr. 2022 Jul 7;9:906186. doi: 10.3389/fnut.2022.906186. eCollection 2022.
7
Comparisons between short-peptide formula and intact-protein formula for early enteral nutrition initiation in patients with acute gastrointestinal injury: a single-center retrospective cohort study.短肽型配方与整蛋白型配方用于急性胃肠损伤患者早期肠内营养启动的比较:一项单中心回顾性队列研究。
Ann Transl Med. 2022 May;10(10):573. doi: 10.21037/atm-22-1837.
8
Gastrointestinal Tolerance and Protein Absorption Markers with a New Peptide Enteral Formula Compared to a Standard Intact Protein Enteral Formula in Critically Ill Patients.新型肽肠内配方与标准完整蛋白肠内配方在危重症患者中的胃肠道耐受性和蛋白质吸收标志物比较。
Nutrients. 2021 Jul 10;13(7):2362. doi: 10.3390/nu13072362.
9
Transition to peptide-based diet improved enteral nutrition tolerance and decreased healthcare utilization in pediatric home enteral nutrition.肽基饮食过渡可改善儿科家庭肠内营养的耐受性并降低医疗保健利用率。
JPEN J Parenter Enteral Nutr. 2022 Mar;46(3):626-634. doi: 10.1002/jpen.2202. Epub 2021 Jul 19.
10
Real-World Evidence of Treatment, Tolerance, Healthcare Utilization, and Costs Among Postacute Care Adult Patients Receiving Enteral Peptide-Based Diets in the United States.美国接受肠内肽基饮食的急性后期护理成年患者的治疗、耐受性、医疗保健利用和成本的真实世界证据。
JPEN J Parenter Enteral Nutr. 2021 Nov;45(8):1729-1735. doi: 10.1002/jpen.2074. Epub 2021 Mar 18.